Litcius/Paper detail

Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis

Neeraj Narula, Emily C L Wong, John K. Marshall, Jean‐Frédéric Colombel, Parambir S. Dulai, Walter Reinisch

2021Clinical Gastroenterology and Hepatology29 citationsDOI

Topics & Concepts

VedolizumabMedicineInfliximabUlcerative colitisInternal medicineGastroenterologyDermatologyTumor necrosis factor alphaDiseaseInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesLiver Diseases and Immunity
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis | Litcius